Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AIM ImmunoTech (AIM) EBIT Margin (2018 - 2023)

Historic EBIT Margin for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to 21544.62%.

  • ImmunoTech's EBIT Margin changed N/A to 21544.62% in Q4 2023 from the same period last year, while for Dec 2023 it was 25996.4%, marking a year-over-year change of. This contributed to the annual value of 11630.59% for FY2024, which is 41694100.0% up from last year.
  • As of Q4 2023, ImmunoTech's EBIT Margin stood at 21544.62%.
  • Over the past 5 years, ImmunoTech's EBIT Margin peaked at 7388.89% during Q1 2020, and registered a low of 21544.62% during Q4 2023.